Pyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for Toxoplasma gondii.

Pyrimethamine pharmacokinetics were studied in 11 human immunodeficiency virus (HIV)-positive patients who were seropositive for exposure to Toxoplasma gondii and were taking zidovudine (AIDS Clinical Trials Group Protocol 102). Pyrimethamine was administered at 50 mg daily for 3 weeks to achieve st...

Full description

Saved in:
Bibliographic Details
Main Authors: Jacobson, J M, Davidian, M, Rainey, P M, Hafner, R, Raasch, R H, Luft, B J
Format: Artigo
Language:Inglês
Published: 1996
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC163331/
https://ncbi.nlm.nih.gov/pubmed/8726001
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items